numares Health is a pioneering metabolomics platform delivering multidimensional biomarker insights and clinical pathways for optimal patient care. Its highly automated digital conversion of biochemical pathways uses NMR spectra to simultaneously measure hundreds of biomarkers from a single, minimally-processed sample, ensuring precise, consistent, scalable and streamlined workflows across labs, clinical trials/treatment and geographies. With robust standardization, incremental tests can also be rapidly processed, even from historically collected spectra, accelerating the pace of clinical research. These digital biomarkers allow the seamless transition from lab bench to bedside, with no further chemical intervention required, dramatically saving costs, while boosting accuracy and efficiency.

numares Health’s 𝘈𝘟𝘐𝘕𝘖𝘕® 𝘚𝘺𝘴𝘵𝘦𝘮 produces analyses of single biomarkers and complex constellations, delivering multidimensional, personalized disease and drug response insights, dramatically improving sensitivity and specificity. This supports prognostic clinical utility, guiding treatment pathways and preventive strategies and enabling the earlier detection of complex conditions. Historic digital sample data can also be re-processed for new metabolite analyses to improve design, stratification and monitoring of clinical trials in drug development. 

Our aim is to revolutionize R&D and treatment in the way that genomic analyses have changed cancer treatment but with far greater scope across intersecting causes of disease. We want to change medicine from diagnosis/management of symptoms to accurately finding and treating underlying causes of disease. 

Numares AG 
Am BioPark 13 
93053 Regensburg 
Phone: +49 941 280 949-00 

E-Mail: info@numares.com www.numares.com 
Executive Board: Florian Voß, Andreas Wolf 
Supervisory Board: Volker Pfahlert (chairman), 
Registered office: Regensburg 
Location of court: Regensburg HRB 14269 
VAT-ID: DE 236 532 262

Numares Health

Org chart

Teams

Offices